Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Pollock

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Nephrology (Carlton, Vic.)|October 14, 2005
The CARI guidelines. Biochemical and haematological targets guidelines. HaemoglobinCarol Pollock, Lawrence McMahon,
Kidney International|April 10, 2018
Drug repurposing in kidney diseaseUsha Panchapakesan, Carol Pollock
Nature Reviews. Nephrology|November 7, 2020
Organ protection beyond glycaemic control with SGLT2 inhibitorsUsha Panchapakesan, Carol Pollock
Advances in Chronic Kidney Disease|December 19, 2021
Sodium-Glucose Cotransporter 2 Inhibition: Rationale and Mechanisms for Kidney and Cardiovascular Protection in People With and Without DiabetesCarol Pollock, Brendon L Neuen
Clinical and Experimental Pharmacology & Physiology|December 16, 2010
Renal epidermal growth factor receptor: its role in sodium and water homeostasis in diabetic nephropathyUsha Panchapakesan, Carol Pollock, Sonia Saad
Nephrology (Carlton, Vic.)|May 16, 2009
Review article: importance of the kidney proximal tubular cells in thiazolidinedione-mediated sodium and water uptakeUsha Panchapakesan, Carol Pollock, Sonia Saad
Clinical Science (London, England : 1979)|September 12, 2012
Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular diseaseUsha Panchapakesan, Amanda Mather, Carol Pollock
International Journal of Nanomedicine|August 29, 2007
Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator)Usha Panchapakesan, Siska Sumual, Carol Pollock
Clinical Science (London, England : 1979)|February 5, 2014
Role of Toll-like receptors in diabetic nephropathyHarshini Mudaliar, Carol Pollock, Usha Panchapakesan
The Australasian Medical Journal|November 8, 2014
SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetesRobert G Moses, Stephen Colagiuri, Carol Pollock
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Nephrology (Carlton, Vic.)|October 14, 2005
The CARI guidelines. Biochemical and haematological targets guidelines. HaemoglobinCarol Pollock, Lawrence McMahon,
Kidney International|April 10, 2018
Drug repurposing in kidney diseaseUsha Panchapakesan, Carol Pollock
Nature Reviews. Nephrology|November 7, 2020
Organ protection beyond glycaemic control with SGLT2 inhibitorsUsha Panchapakesan, Carol Pollock
Advances in Chronic Kidney Disease|December 19, 2021
Sodium-Glucose Cotransporter 2 Inhibition: Rationale and Mechanisms for Kidney and Cardiovascular Protection in People With and Without DiabetesCarol Pollock, Brendon L Neuen
Clinical and Experimental Pharmacology & Physiology|December 16, 2010
Renal epidermal growth factor receptor: its role in sodium and water homeostasis in diabetic nephropathyUsha Panchapakesan, Carol Pollock, Sonia Saad
Nephrology (Carlton, Vic.)|May 16, 2009
Review article: importance of the kidney proximal tubular cells in thiazolidinedione-mediated sodium and water uptakeUsha Panchapakesan, Carol Pollock, Sonia Saad
Clinical Science (London, England : 1979)|September 12, 2012
Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular diseaseUsha Panchapakesan, Amanda Mather, Carol Pollock
International Journal of Nanomedicine|August 29, 2007
Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator)Usha Panchapakesan, Siska Sumual, Carol Pollock
Clinical Science (London, England : 1979)|February 5, 2014
Role of Toll-like receptors in diabetic nephropathyHarshini Mudaliar, Carol Pollock, Usha Panchapakesan
The Australasian Medical Journal|November 8, 2014
SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetesRobert G Moses, Stephen Colagiuri, Carol Pollock
Pageof 17